Poolbeg Pharma IPO and funds raised provide strong platform to begin rapid growth plan

A pharmaceutical company has announced its admission to trading on the London Stock Exchange (IPO) on Monday following a £50m oversubscribed fundraising raised by investor investors in the past few years. Following the announcement, it is expected to become the first privately-owned company to sell shares in London.

Source: directorstalkinterviews.com
Published on 2021-07-19